查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2004057

输尿管镜设备市场：全球市场预测（按设备类型、技术、配件、应用和最终用户划分）—2026-2032年

Ureteroscopy Devices Market by Device Type, Technology, Accessories, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，输尿管镜设备市场价值将达到 23.1 亿美元，到 2026 年将成长至 24.7 亿美元，到 2032 年将达到 38 亿美元，复合年增长率为 7.33%。

主要市场统计数据
基准年 2025 23.1亿美元
预计年份：2026年 24.7亿美元
预测年份 2032 38亿美元
复合年增长率 (%) 7.33%

本报告从临床需求、技术进步、采购趋势以及对策略性相关人员的影响等方面，全面说明了输尿管镜设备的演变。

输尿管镜设备处于泌尿系统手术创新和微创医疗的交汇点，同时满足了临床医生、医疗系统和患者对提高视野清晰度、降低手术风险和加快术后恢復的需求。对精准治疗结石和尿路上皮病变的临床需求持续推动着人们对光学系统、能量输送系统以及相关一次性耗材的关注，这些设备旨在优化结石取出和肿瘤消融的过程。同时，医院和门诊手术中心不断变化的优先事项影响着采购週期和设备选择，而监管和报销环境则阻碍了设备的普及应用。

正在重塑输尿管镜检查的临床实践、技术应用和商业策略的变革性变化。

输尿管镜器材的市场格局正经历多重融合的变革，这些变革正在改变临床实践和商业性决策。首先，高解析度数位光学技术的成熟改变了临床医师对影像品质和术中决策的预期，使得病灶的表征更加精细，治疗方案也更加可靠。此外，输尿管镜与手术室视觉化系统和影像管理系统的深度整合也进一步推动了这项变革，共同提升了输尿管镜在复杂诊断和治疗流程中的作用。

2025年美国关税措施对供应链建置、采购决策及成本透明度的累积影响。

近期公布的关税措施和2025年贸易政策发展趋势，使得输尿管镜设备产业的供应链配置对企业而言变得更加关键。针对特定医疗设备原料和成品的关税调整，迫使製造商和经销商重新评估其采购地点、近岸外包方案和库存策略，以维持成本竞争力和按时交付的可靠性。为此，各企业正日益关註二级和三级供应商的依赖关係，以识别关税补贴商品可能受到的影响，并制定风险缓解策略，包括重新谈判合约、寻找替代采购管道以及选择性垂直整合等。

基于细分市场的洞察：将医疗设备类型、临床应用、终端用户环境、技术进步和配件生态系统转化为策略重点。

有效的商业策略始于对细分市场的精准理解。在考虑器械类型时，必须区分软性输尿管镜和半硬性系统。在软性输尿管镜产品系列中，又存在进一步的差异：一是优先考虑高清视觉化的数位软性平台，二是专注于传统光纤传输架构的光纤软性平台。这些器械层面的选择会影响手术范围、维修和再处理成本以及资金预算分配，每种选择都需要不同的临床证据和培训方法来促进其推广应用。

区域洞察聚焦在美洲、欧洲、中东和非洲以及亚太地区的采用趋势和结构差异，以及对打入市场策略。

地理环境对医疗器材的普及和商业性化应用有显着影响。在美洲，大规模综合医疗保健系统、众多私人医院以及蓬勃发展的门诊手术中心网络，共同推动了对高通量一次性产品和功能丰富的可重复使用平台的需求。该地区的医保报销机制和资本规划週期往往侧重于临床效率的显着提升和可预测的单次手术成本，这影响着医院和门诊环境中对产品的评估方式。此外，该地区为优化临床流程所做的努力以及医院整合的趋势，也影响采购规模和标准化机会。

公司层面的洞察，聚焦于产品组合差异化、製造地、智慧财产权趋势和伙伴关係模式。

输尿管镜器材领域的竞争动态取决于各公司如何建构产品系列，涵盖可重复使用的光学元件、一次性光学元件、能量供应系统和配套配件。领先的创新者优先考虑整合解决方案，这些方案结合了高解析度视觉化、优化的雷射相容性和客製化的附件生态系统，以建立高度永续的临床工作流程。中型公司通常强调针对特定治疗领域的价值提案，例如经济高效的一次性产品或专用篮框和光纤。

为行业领导者提供实用建议，以加速采用、增强韧性，并在临床和商业途径中获取价值。

产业领导者应优先考虑模组化产品组合策略，平衡可重复使用和一次性使用模式。具体而言，应重点关注设定时间、消毒负担和配件相容性，并根据门诊手术中心和医院的实际运作情况设计产品，这将有助于推动更广泛的应用。此外，有针对性的临床证据项目，能够证明手术效率和以患者为中心的疗效，将在与大规模医疗机构和保险公司的谈判中发挥关键作用。

本报告概述了得出所呈现的研究结果的调查方法，包括数据三角测量、专家参与、检验通讯协定和分析框架。

本报告基于多方面的研究方法，结合了对临床医生、采购经理和行业高管的专家访谈，以及对监管文件、临床文献和医疗设备技术研究途径的二次研究。主要研究包括结构化访谈，旨在了解医院和门诊环境中的手术流程、医疗设备选择标准和采购标准。二次分析检验了有关临床模式和技术性能的声明，重点关注医疗设备的设计特点、配件相容性和已发表的临床结果。

对于希望根据执行摘要中的见解采取行动的相关人员，本结论整合了策略意义，并概述了下一步的优先步骤。

输尿管镜器材市场正处于转折点，其驱动力来自光学、能量传输技术和配件设计的融合，以及采购和医疗服务模式的转变。这些因素为那些能够根据医院和门诊手术中心的营运需求调整产品功能，同时兼顾供应链韧性和不断变化的贸易政策风险的公司创造了明确的机会。能否成功推广应用取决于能否证明其临床价值、简化手术流程，以及在不同的医疗环境中实现可预测的营运经济效益。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：输尿管镜设备市场：依设备类型划分

  • 软性输尿管镜
    • 数位柔性
    • 光纤柔性
  • 半硬式输尿管镜

第九章：输尿管镜设备市场：依技术分类

  • 数位输尿管镜
    • 可重复使用的
    • 一次性的
  • 纤维光输尿管镜
    • 可重复使用的
    • 一次性的

第十章：输尿管镜设备市场：依配件划分

  • 雷射光纤
    • 钬雷射光纤
    • 铥雷射光纤
  • 石篮
    • 标准篮
    • 没有倾斜的篮子

第十一章 输尿管镜设备市场：依应用领域划分

  • 诊断
    • 检查
    • 视觉化
  • 治疗
    • 石材管理
      • 篮式撷取
      • 石头碎裂
    • 肿瘤管理
      • 切片检查
      • 雷射消熔

第十二章 输尿管镜设备市场：依最终用户划分

  • 门诊手术中心
    • 独立的
    • 医院附属机构
  • 医院

第十三章 输尿管镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 输尿管镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 输尿管镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国输尿管镜设备市场

第十七章：中国输尿管镜设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advin Health Care
  • Ambu A/S
  • Boston Scientific Corporation
  • Cliniva Healthcare
  • Coloplast A/S
  • ConMed Corporation
  • Cook Medical LLC
  • Dornier MedTech
  • EMS Electro Medical Systems SA
  • Fujifilm Holdings Corporation
  • KARL STORZ SE & Co. KG
  • LocaMed Limited
  • Maxer Endoscopy GmbH
  • Medtronic plc
  • MicroPort Urocare
  • Olympus Corporation
  • OTU Medical
  • PENTAX Medical
  • Richard Wolf GmbH
  • ROCAMED
  • Stryker Corporation
  • Teleflex Incorporated
  • Vimex Endoscopy
Product Code: MRR-4659C87137F4

The Ureteroscopy Devices Market was valued at USD 2.31 billion in 2025 and is projected to grow to USD 2.47 billion in 2026, with a CAGR of 7.33%, reaching USD 3.80 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.31 billion
Estimated Year [2026] USD 2.47 billion
Forecast Year [2032] USD 3.80 billion
CAGR (%) 7.33%

A comprehensive introduction framing ureteroscopy device evolution across clinical demand, technology progress, procurement dynamics, and implications for strategic stakeholders

Ureteroscopy devices sit at the intersection of urology procedural innovation and minimally invasive care delivery, responding to simultaneous pressures from clinicians, healthcare systems, and patients for improved visualization, reduced procedural risk, and faster recovery. The clinical imperative to manage stone disease and urothelial lesions with precision has driven sustained interest in optics, energy delivery, and ancillary disposables that enhance stone extraction and tumor ablation workflows. Concurrently, evolving hospital and ambulatory surgical center priorities influence procurement cycles and device preference, while regulatory and reimbursement environments shape the speed of adoption.

Technological advances in digital imaging and single-use platforms have catalyzed reconsideration of capital and operating models across care settings. Digital flexible ureteroscopes have elevated image clarity and integration with ancillary imaging systems, while single-use offerings have emerged in response to sterilization complexity, cross-contamination concerns, and throughput constraints. At the same time, developments in laser technology and accessory design-such as baskets and fibers engineered for improved maneuverability and fragmentation efficiency-have narrowed the procedural trade-offs that clinicians weigh during device selection.

In this context, stakeholders must balance clinical efficacy, total procedural cost, and supply resilience. As care pathways decentralize and outpatient settings take on a larger share of urologic procedures, alignment between device design and operating environment becomes a critical determinant of commercial success. The remainder of this summary synthesizes the most consequential shifts, regulatory and trade impacts, segmentation-driven implications, regional nuances, and clear recommendations for leaders seeking to position their portfolios effectively.

Transformative Shifts Reshaping Clinical Practice, Technology Adoption, and Commercial Strategy in Ureteroscopy

The landscape for ureteroscopy devices is undergoing several convergent transformations that are altering clinical practice and commercial calculus. First, the maturation of high-resolution digital optics has changed clinician expectations for image quality and intraoperative decision making, enabling finer lesion characterization and more confident therapeutic maneuvers. This shift is reinforced by better integration with operating room visualization suites and image management systems, which together advance the role of ureteroscopy in complex diagnostic and therapeutic pathways.

Second, the rise of single-use technology is reshaping procurement models and infection control strategies. Facilities increasingly evaluate single-use options not solely on per-procedure cost but on throughput, reprocessing labor, and cross-infection risk mitigation. This has led to hybrid adoption patterns in which reusable and single-use systems coexist, with purchasing decisions driven by procedure volume, sterilization capacity, and clinical preference.

Third, energy delivery and accessory innovation, especially in laser fiber performance and basket design, are shifting the boundary of what can be achieved endoscopically. Improvements in lithotripsy efficiency and tumor ablation precision reduce the need for staged procedures and broaden the patient population eligible for minimally invasive management. These clinical gains translate into shifting procedural mixes across inpatient and ambulatory venues.

Finally, decentralized care delivery and growth in ambulatory surgical centers are prompting manufacturers to refine product portfolios for portability, simplified setup, and rapid turnover. Taken together, these shifts create both opportunity and complexity for product developers and health system partners, demanding coordinated investments in clinical training, evidence generation, and supply chain agility to realize potential gains.

Cumulative Impacts of United States Tariff Actions in 2025 on Supply Chain Structuring, Sourcing Decisions, and Cost Transparency

Recent tariff actions and trade policy signals announced for 2025 have increased the salience of supply chain configuration for companies operating in the ureteroscopy device space. Tariff adjustments applied to certain medical device inputs and finished goods have prompted manufacturers and distributors to reassess sourcing footprints, nearshoring options, and inventory strategies to preserve cost competitiveness and delivery reliability. In response, organizations are increasingly mapping supplier dependencies at the tier-two and tier-three levels to identify latent exposure to tariffed goods and to develop mitigation plans that span contract renegotiation, alternative sourcing, and selective vertical integration.

These policy shifts also influence pricing transparency and contractual negotiation dynamics with health systems and group purchasing organizations. Providers are demanding greater visibility into landed costs and contingency provisions, and procurement cycles now frequently incorporate clauses addressing import duties and supply interruptions. The cumulative effect has been a heightened emphasis on scenario planning and stress-testing commercial models under different trade policy trajectories.

On the manufacturing side, some firms are accelerating localized assembly or qualifying alternate contract manufacturers in non-tariff jurisdictions to reduce duty burden and shorten lead times. Others are redesigning component specifications to minimize the use of tariff-implicated items, while a subset is leveraging tariff mitigation mechanisms where available. Importantly, these responses are not uniform; small and mid-sized companies face different constraints compared with large established firms, which affects competitive dynamics and potential consolidation activity.

Going forward, the interplay between tariff policy and global medical device trade will continue to shape investment choices, strategic partnerships, and the relative attractiveness of reusable versus disposable device models, as duty-sensitive cost components flow through to procurement decisions and clinical adoption patterns.

Segmentation-driven insights translating device type, clinical application, end-user environment, technology pathways, and accessory ecosystems into strategic priorities

An effective commercial strategy begins with precise segment-level understanding. Device type considerations differentiate flexible ureteroscopes from semi-rigid systems; within flexible offerings, a further distinction exists between digital flexible platforms that prioritize high-definition visualization and fiber-optic flexible variants that emphasize traditional light-transmitting architectures. These device-level choices affect procedure scope, repair and reprocessing burdens, and capital budget allotments, and they require distinct clinical evidence and training approaches to drive adoption.

Application-level segmentation separates diagnostic use from therapeutic deployment. Diagnostic applications emphasize inspection and visualization capabilities necessary for lesion detection and mapping, while therapeutic use cases split between stone management and tumor management. Stone management workflows further bifurcate into basket extraction strategies and lithotripsy-centric approaches, each demanding specific accessory compatibility and procedural ergonomics. Tumor management workflows rely on precise biopsy capability and laser ablation performance, which in turn influence device optics, deflection, and energy delivery requirements.

End-user context plays a critical role in adoption patterns. Ambulatory surgical centers, whether freestanding or hospital-affiliated, prioritize throughput efficiency, simplified reprocessing, and predictable per-case operating expenses, whereas hospitals, whether private or public, weigh capital depreciation, breadth of procedural mix, and service-level expectations when selecting devices. These differences drive varied commercial messaging, reimbursement engagement, and deployment models across providers.

Technology segmentation highlights the parallel development of digital and fiber-optic ureteroscopes, each available in reusable and single-use configurations. Strategic choices between reusable and single-use variants hinge on sterilization infrastructure, procedural volume, and long-term cost-of-ownership calculus. Finally, accessory segmentation-such as distinctions between laser fibers and stone baskets and between holmium and thulium fibers or standard and tipless baskets-shapes bundled offering opportunities and aftermarket revenue potential. Aligning product roadmaps to these layered segments enables focused evidence generation, tailored value propositions, and differentiated commercial execution.

Regional insights highlighting adoption dynamics and structural differences across the Americas, Europe Middle East & Africa, and Asia-Pacific with implications for go-to-market strategies

Geographic context materially influences device adoption and commercial execution. In the Americas, large integrated health systems, a strong private hospital presence, and active ambulatory surgical center networks create demand for both high-throughput disposables and feature-rich reusable platforms. Reimbursement structures and capital planning cycles in this region often favor demonstrable clinical efficiency gains and predictable per-procedure costing, which shapes how products are evaluated across hospital and ambulatory settings. Additionally, pathway optimization initiatives and hospital consolidation trends in this region affect purchasing scale and standardization opportunities.

Within Europe, the Middle East & Africa, diversity in reimbursement models, regulatory timelines, and health infrastructure results in differentiated uptake patterns. High-resource markets place a premium on advanced imaging and single-use infection control benefits, while emerging healthcare systems emphasize durable, repairable devices supported by local service networks. Procurement in these markets may also be influenced by national contracting vehicles and regional distributors, necessitating tailored pricing and service propositions.

Asia-Pacific presents a mix of rapid adoption in urban tertiary centers and widening access in regional hospitals and ambulatory facilities. Investments in minimally invasive urology and expanding surgical capacity within the region favor scalable device solutions that balance capital expenditure with per-case economics. Partnerships with local manufacturers and distributors, along with training programs oriented toward procedure standardization, are particularly effective in accelerating adoption across diverse healthcare settings in Asia-Pacific.

Understanding these regional nuances allows manufacturers to prioritize evidence generation, regulatory strategy, and commercial models that align with local procurement behavior, reimbursement priorities, and operational realities.

Company-level insights focusing on portfolio differentiation, manufacturing footprint, intellectual property trends, and partnership models

Competitive dynamics in the ureteroscopy devices space are shaped by how firms configure product portfolios across reusable and disposable optics, energy delivery systems, and complementary accessories. Leading innovators prioritize integrated solutions that combine high-resolution visualization with optimized laser compatibility and bespoke accessory ecosystems to create sticky clinical workflows. Mid-market players frequently emphasize targeted value propositions-such as cost-effective single-use offerings or specialized baskets and fibers-to capture specific procedural niches.

Manufacturing footprint and vertical capability influence competitive positioning. Firms with diversified production and regional assembly capabilities can respond more flexibly to tariff shifts and supply disruptions, while those relying on concentrated manufacturing face different risk profiles. Partnerships with contract manufacturers, strategic alliances for component sourcing, and co-development agreements with clinical opinion leaders help expand product breadth without undermining balance sheets.

Intellectual property and regulatory strategy further differentiate companies. Proprietary imaging software, unique deflection mechanisms, and fiber technologies create barriers to entry and enable premium positioning when accompanied by rigorous clinical validation. At the same time, firms that effectively leverage aftermarket revenue through accessories, consumables, and service agreements strengthen recurring revenue streams and deepen customer relationships.

Finally, go-to-market approaches vary from direct sales models focused on high-touch clinical training and hospital integration to distributor-led strategies that prioritize broader geographic reach. The most successful organizations align their commercial model with the end-user segmentation and regional realities described earlier, investing in clinical evidence, education programs, and service networks that address the practical needs of clinicians and procurement teams.

Actionable recommendations for industry leaders to accelerate adoption, strengthen resilience, and capture value across clinical and commercial pathways

Industry leaders should prioritize modular portfolio strategies that reconcile the coexistence of reusable and single-use modalities. Specifically, aligning product design with the operational realities of ambulatory surgical centers and hospitals-focusing on setup time, sterilization burden, and accessory compatibility-will support wider adoption. In tandem, targeted clinical evidence programs that demonstrate procedural efficiency gains and patient-centered outcomes will be decisive in conversations with high-volume institutions and payers.

Supply chain resilience must be elevated to a strategic priority. Companies should expand multi-sourcing capabilities for critical components, qualify regional assembly partners where feasible, and implement inventory buffering for tariff-sensitive inputs. These actions reduce exposure to trade policy shifts and support predictable delivery performance for key customers.

Commercially, firms should adopt differentiated engagement models that reflect end-user segmentation. High-touch programs emphasizing hands-on training, proctoring, and outcomes tracking work well for tertiary hospitals, while streamlined procurement options and predictable per-case costing resonate with ambulatory surgical centers. Bundled offerings that package scopes, optimized laser fibers, and compatible baskets can simplify purchasing decisions and create measurable total cost of care narratives.

Finally, invest in digital enablement and data capture to quantify procedure-level performance and support value-based conversations with providers. Tele-mentoring, remote diagnostics for device health, and analytics reporting on utilization create additional revenue and service differentiation opportunities while reinforcing clinical trust and long-term partnerships.

Research methodology outlining data triangulation, expert engagement, validation protocols, and analytical frameworks used to derive the insights presented

This synthesis is grounded in a multi-source research approach that integrates primary expert interviews with clinicians, procurement leaders, and industry executives, combined with secondary examination of regulatory filings, clinical literature, and device technical specifications. The primary input included structured interviews designed to capture procedural workflows, device preferences, and procurement criteria across hospital and ambulatory settings. Secondary analysis focused on device design features, accessory compatibility, and published clinical outcomes to validate practice patterns and technology performance claims.

The analysis employed a segmentation-first framework to ensure that insights were relevant to device type, clinical application, end-user environment, technology configuration, and accessory ecosystems. Cross-validation protocols compared interview-based observations against product literature and public regulatory records to confirm claims regarding device capabilities and intended use cases. Sensitivity checks addressed potential bias from single-source testimony by weighting input across multiple clinical and commercial stakeholders.

Interpretation of tariff impacts and supply chain responses combined policy review with supplier-level disclosure and procurement leader perspectives to generate a practical view of likely strategic responses. The regional analysis drew on clinician interviews in representative markets and review of reimbursement and procurement structures to surface realistic adoption constraints and enablers. Together, these methodological elements produced an evidence-informed synthesis designed to support decision makers in commercial planning and product strategy.

Conclusion synthesizing strategic implications and outlining priority next steps for stakeholders seeking to act on the executive summary findings

The ureteroscopy device landscape is at an inflection point defined by converging advances in optics, energy delivery, and accessory design coupled with shifting procurement and care delivery models. These forces create distinct opportunities for firms that can align product functionality with the operational needs of hospitals and ambulatory surgical centers, while simultaneously addressing supply chain resilience and evolving trade policy risk. Adoption choices will hinge on the ability to demonstrate clinical value, simplify procedural workflows, and deliver predictable operating economics for diverse care settings.

Priority next steps for stakeholders include clarifying segment-specific value propositions, accelerating targeted clinical evidence that maps to end-user priorities, and strengthening manufacturing and sourcing flexibility to respond to tariff and logistics disruptions. Organizations should also refine commercial approaches to reflect regional reimbursement realities and to adapt messaging for distinct buyer types across private hospitals, public hospitals, freestanding ambulatory facilities, and hospital-affiliated outpatient centers.

By focusing on these strategic imperatives, companies and provider partners can better navigate the evolving landscape, capture opportunities presented by technological innovation, and deliver improved outcomes for patients undergoing diagnostic and therapeutic ureteroscopic procedures. The remainder of the report offers the detailed appendices and evidence base required to operationalize these conclusions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ureteroscopy Devices Market, by Device Type

  • 8.1. Flexible Ureteroscopes
    • 8.1.1. Digital Flexible
    • 8.1.2. Fiber-Optic Flexible
  • 8.2. Semi-Rigid Ureteroscopes

9. Ureteroscopy Devices Market, by Technology

  • 9.1. Digital Ureteroscopes
    • 9.1.1. Reusable
    • 9.1.2. Single Use
  • 9.2. Fiber-Optic Ureteroscopes
    • 9.2.1. Reusable
    • 9.2.2. Single Use

10. Ureteroscopy Devices Market, by Accessories

  • 10.1. Laser Fibers
    • 10.1.1. Holmium Laser Fibers
    • 10.1.2. Thulium Laser Fibers
  • 10.2. Stone Baskets
    • 10.2.1. Standard Baskets
    • 10.2.2. Tipless Baskets

11. Ureteroscopy Devices Market, by Application

  • 11.1. Diagnostic
    • 11.1.1. Inspection
    • 11.1.2. Visualization
  • 11.2. Therapeutic
    • 11.2.1. Stone Management
      • 11.2.1.1. Basket Extraction
      • 11.2.1.2. Lithotripsy
    • 11.2.2. Tumor Management
      • 11.2.2.1. Biopsy
      • 11.2.2.2. Laser Ablation

12. Ureteroscopy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
    • 12.1.1. Freestanding
    • 12.1.2. Hospital Affiliated
  • 12.2. Hospitals

13. Ureteroscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ureteroscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ureteroscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ureteroscopy Devices Market

17. China Ureteroscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Advin Health Care
  • 18.6. Ambu A/S
  • 18.7. Boston Scientific Corporation
  • 18.8. Cliniva Healthcare
  • 18.9. Coloplast A/S
  • 18.10. ConMed Corporation
  • 18.11. Cook Medical LLC
  • 18.12. Dornier MedTech
  • 18.13. EMS Electro Medical Systems S.A.
  • 18.14. Fujifilm Holdings Corporation
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. LocaMed Limited
  • 18.17. Maxer Endoscopy GmbH
  • 18.18. Medtronic plc
  • 18.19. MicroPort Urocare
  • 18.20. Olympus Corporation
  • 18.21. OTU Medical
  • 18.22. PENTAX Medical
  • 18.23. Richard Wolf GmbH
  • 18.24. ROCAMED
  • 18.25. Stryker Corporation
  • 18.26. Teleflex Incorporated
  • 18.27. Vimex Endoscopy

LIST OF FIGURES

  • FIGURE 1. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URETEROSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL URETEROSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GCC URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. GCC URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 256. GCC URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. GCC URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 260. GCC URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 261. GCC URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 262. GCC URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. GCC URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 264. GCC URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 265. GCC URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 266. GCC URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 267. GCC URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. GCC URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. G7 URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 304. G7 URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 305. G7 URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 307. G7 URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 308. G7 URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 309. G7 URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 310. G7 URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. G7 URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 312. G7 URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 313. G7 URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 314. G7 URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 315. G7 URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. G7 URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 318. NATO URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. NATO URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 320. NATO URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 321. NATO URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 322. NATO URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2032 (USD MILLION)
  • TABLE 323. NATO URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 324. NATO URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2032 (USD MILLION)
  • TABLE 325. NATO URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2032 (USD MILLION)
  • TABLE 326. NATO URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLI